Characterization of the First Carbapenem-Resistant Pseudocitrobacter faecalis Harboring blaOXA-181 in China

With the wide use of carbapenems, carbapenem-resistant Enterobacterales have been increasingly reported worldwide. In this study, one blaOXA-181-positive Pseudocitrobacter faecalis strain was isolated from the blood culture of a patient with a bloodstream infection in China, which was its first clinical report outside Pakistan. Species identification of P. faecalis was initially performed using MALDI-TOF/MS and further confirmed by 16S rRNA gene and housekeeping gene sequencing. The antimicrobial susceptibility testing was determined through the broth microdilution method, and their clonal relationship was analyzed by pulsed-field gel electrophoresis. To study the transmission and genetic structure of the blaOXA-181 gene, a transformation test and whole-genome sequencing (WGS) were performed. The results of the antimicrobial susceptibility testing indicated this P. faecalis was resistant to carbapenems, quinolones, and commonly used β-lactam/β-lactamase inhibitor combinations. Through WGS and transformation experiments, blaOXA-181 and qnrS1 genes causing antibiotic resistance were located on a 55,148-bp length IncX3 type plasmid with a truncated ColKp3 replicon gene. As a rare species of Enterobacterales, P. faecalis was clinically reported in China for the first time, and the blaOXA-181 gene it carried was located on a globally disseminated IncX3 plasmid. The spread of such bacteria and antibiotic resistance requires more clinical attention.

[1]  L. Cerdeira,et al.  Carbapenem-resistant IMP-1-producing Pseudocitrobacter vendiensis emerging in a hemodialysis unit , 2022, Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology].

[2]  F. Hu,et al.  First Report of blaIMP–4 and blaSRT–2 Coproducing Serratia marcescens Clinical Isolate in China , 2021, Frontiers in Microbiology.

[3]  M. Tilahun,et al.  Emerging Carbapenem-Resistant Enterobacteriaceae Infection, Its Epidemiology and Novel Treatment Options: A Review , 2021, Infection and drug resistance.

[4]  P. V. van Genderen,et al.  Destination shapes antibiotic resistance gene acquisitions, abundance increases, and diversity changes in Dutch travelers , 2021, Genome Medicine.

[5]  L. Schouls,et al.  bla OXA-48-like genome architecture among carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in the Netherlands , 2021, Microbial genomics.

[6]  Zhixin Liang,et al.  The proportion, species distribution and dynamic trends of bloodstream infection cases in a tertiary hospital in China, 2010–2019 , 2021, Infection.

[7]  G. Alvarado,et al.  Genotyping and differential bacterial inhibition of Batrachochytrium dendrobatidis in threatened amphibians in Costa Rica. , 2021, Microbiology.

[8]  W. van Schaik,et al.  Emergence of carbapenem-resistant Klebsiella pneumoniae harbouring bla OXA-48-like genes in China , 2021, Journal of medical microbiology.

[9]  Jianzhong Shen,et al.  High prevalence and persistence of carbapenem and colistin resistance in livestock farm environments in China. , 2020, Journal of hazardous materials.

[10]  F. Hu,et al.  Dissemination of Carbapenemases (KPC, NDM, OXA-48, IMP, and VIM) Among Carbapenem-Resistant Enterobacteriaceae Isolated From Adult and Children Patients in China , 2020, Frontiers in Cellular and Infection Microbiology.

[11]  F. Breidt,et al.  Bacteriophages Infecting Gram-Negative Bacteria in a Commercial Cucumber Fermentation , 2020, Frontiers in Microbiology.

[12]  Hongwei Zhou,et al.  First Report of OXA-181-Producing Klebsiella pneumoniae in China , 2020, Infection and drug resistance.

[13]  F. Hu,et al.  CHINET efforts to control antibacterial resistance in China. , 2020, Journal of global antimicrobial resistance.

[14]  Robin Patel,et al.  Molecular and clinical epidemiology of carbapenem-resistant Enterobacterales in the USA (CRACKLE-2): a prospective cohort study. , 2020, The Lancet. Infectious diseases.

[15]  J. Timsit,et al.  Bloodstream infections in critically ill patients: an expert statement , 2020, Intensive Care Medicine.

[16]  L. Schouls,et al.  Molecular characteristics of carbapenemase-producing Enterobacterales in the Netherlands; results of the 2014-2018 national laboratory surveillance. , 2020, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[17]  T. V. Van Boeckel,et al.  Global Geographic Trends in Antimicrobial Resistance: The Role of International Travel. , 2019, Journal of travel medicine.

[18]  J. Blom,et al.  Taxonomic reassessment of the genus Pseudocitrobacter using whole genome sequencing: Pseudocitrobacter anthropi is a later heterotypic synonym of Pseudocitrobacter faecalis and description of Pseudocitrobacter vendiensis sp. nov. , 2019, International journal of systematic and evolutionary microbiology.

[19]  G. Peirano,et al.  The Global Ascendency of OXA-48-Type Carbapenemases , 2019, Clinical Microbiology Reviews.

[20]  Jianzhong Shen,et al.  Inter-host Transmission of Carbapenemase-Producing Escherichia coli among Humans and Backyard Animals , 2019, Environmental health perspectives.

[21]  Jan A. Roth,et al.  Early versus late onset bloodstream infection during neutropenia after high-dose chemotherapy for hematologic malignancy , 2019, Infection.

[22]  A. Carattoli,et al.  Epidemic IncX3 plasmids spreading carbapenemase genes in the United Arab Emirates and worldwide , 2019, Infection and drug resistance.

[23]  Xin Sun,et al.  The clinical impacts and risk factors for non-central line-associated bloodstream infection in 5046 intensive care unit patients: an observational study based on electronic medical records , 2019, Critical Care.

[24]  F. Hu,et al.  Current Status and Trends of Antibacterial Resistance in China. , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[25]  S. Beatson,et al.  Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance: A Randomized Clinical Trial , 2018, JAMA.

[26]  E. Orlova,et al.  Structure of a VirD4 coupling protein bound to a VirB type IV secretion machinery , 2017, The EMBO journal.

[27]  C. Boev,et al.  Hospital-Acquired Infections: Current Trends and Prevention. , 2017, Critical care nursing clinics of North America.

[28]  Jianzhong Shen,et al.  Comprehensive resistome analysis reveals the prevalence of NDM and MCR-1 in Chinese poultry production , 2017, Nature Microbiology.

[29]  Xiaoli Wang,et al.  Epidemiology of Klebsiella pneumoniae bloodstream infections in a teaching hospital: factors related to the carbapenem resistance and patient mortality , 2016, Antimicrobial Resistance & Infection Control.

[30]  P. Nordmann,et al.  High Prevalence of Carbapenemase-Producing Enterobacteriaceae among Hospitalized Children in Luanda, Angola , 2016, Antimicrobial Agents and Chemotherapy.

[31]  N. Guizani,et al.  Hiding in Fresh Fruits and Vegetables: Opportunistic Pathogens May Cross Geographical Barriers , 2016, International journal of microbiology.

[32]  Z. Zong,et al.  First Report of OXA-181-Producing Escherichia coli in China and Characterization of the Isolate Using Whole-Genome Sequencing , 2015, Antimicrobial Agents and Chemotherapy.

[33]  P. Kämpfer,et al.  Pseudocitrobacter gen. nov., a novel genus of the Enterobacteriaceae with two new species Pseudocitrobacter faecalis sp. nov., and Pseudocitrobacter anthropi sp. nov, isolated from fecal samples from hospitalized patients in Pakistan. , 2014, Systematic and applied microbiology.

[34]  Sergey I. Nikolenko,et al.  SPAdes: A New Genome Assembly Algorithm and Its Applications to Single-Cell Sequencing , 2012, J. Comput. Biol..

[35]  P. Nordmann,et al.  Multiplex PCR for detection of acquired carbapenemase genes. , 2011, Diagnostic microbiology and infectious disease.

[36]  G. P. Harding,et al.  A general method for detecting and sizing large plasmids. , 1995, Analytical biochemistry.

[37]  J. Karlowsky,et al.  Comparative Review of the Carbapenems , 2012, Drugs.

[38]  P. Wayne CLINICAL AND LABORATORY STANDARDS INSTITUTE. PERFORMANCE STANDARDS FOR ANTIMICROBIAL SUSCEPTIBILITY TESTING , 2011 .

[39]  M. Argyres,et al.  Hospital-acquired infections due to gram-negative bacteria. , 2010, The New England journal of medicine.